chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea; Nausea; Headache; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle aches) and NAUSEA (Nausea) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Muscle aches). On 15-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle aches) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.  No concomitant medications reported by reporter. Treatment medication not reported.
sore arm; body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN (body ache) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced  PAIN (body ache), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm), and. At the time of the report,  PAIN (body ache), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm), outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Pt experienced redness, swelling at injection site for one day post vax. No irritability, fever and minimal pain.
Ongoing hospitalization began 9/14/2021. Oxygen via nasal cannula, zinc, vitamin D, Thiamine, Vit C, Decadron 6mg IV, remdesivir IV,
Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe
Vomit; Unable to sleep; Waking up soaking wet; Out of his mind; 101/104F fever; Major chills; Body aches; All joints of the body ache; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Unable to sleep), NIGHT SWEATS (Waking up soaking wet), FEELING ABNORMAL (Out of his mind), PYREXIA (101/104F fever) and CHILLS (Major chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Blood pressure abnormal. Concomitant products included MULTIVITAMIN [VITAMINS NOS], CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]), TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), TESTOSTERONE, ASPIRIN [ACETYLSALICYLIC ACID] and CLONAZEPAM for an unknown indication.    On 23-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Sep-2021, the patient experienced INSOMNIA (Unable to sleep), NIGHT SWEATS (Waking up soaking wet), FEELING ABNORMAL (Out of his mind), PYREXIA (101/104F fever), CHILLS (Major chills), MYALGIA (Body aches) and ARTHRALGIA (All joints of the body ache). On an unknown date, the patient experienced VOMITING (Vomit). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, INSOMNIA (Unable to sleep), NIGHT SWEATS (Waking up soaking wet), FEELING ABNORMAL (Out of his mind), PYREXIA (101/104F fever), CHILLS (Major chills), MYALGIA (Body aches), ARTHRALGIA (All joints of the body ache) and VOMITING (Vomit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Sep-2021, Body temperature: high (High) 101/104F fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants also include turmeric, cardecentin and pain medication. No treatment medication was reported.
Patient had for about one week significant escalation of palpitations. She has had a baseline of rare palpitations, but this escalation was sufficient that she declined further vaccine. It subsequently declined to baseline.
series of 2 covid pfizer vaccine 3/8/2021 and 3/29/2021 at pharmacy.  next 24 hours achy body.  Diagnosed with bells palsy the morning of 4/2/2021. Numbness and drooping on right side of face. Unable to blink or smile. could not eat or drink. Went to local urgent care immediately and then to hospital emergency room. was checked for stroke, determined to be bells palsy. sent home with 7 day prescription of prednisone.
By mid noon 12hrs low grade temp, chills, 32 hours, 102 temp, chills, malaise, high temp for 3 days, respiratory symptoms began within 24 hours, sniffles, irritable throat. 72 hours began Zithromax for diagnosed pneumonia.
Swollen red welt at injection site and radiating nerve pain to hands for about 3 days after injection.
Chest tightness, shortness of breath, and sore throat. Patient denied any difficulty breathing or swallowing.  Patient stated that upon administration of the flu shot in the past, she had chest pain. Patient received Benadryl, Pepcid, Solu-Medrol, and fluids in the emergency department.  Her symptoms resolved and she was discharged with prescription for prednisone.
No adverse effect reported; a female patient was administered properly stored M-M-R II instead of VARIVAX; This spontaneous report was received from a practice manager regarding a 22-year-old female patient. There was no information reported regarding the patient's pertinent medical history, concurrent conditions, concomitant medications and drug allergies/reactions.  On 20-JUN-2019, the patient was administered a properly stored dose of M-M-R II (lot number R024907 and expiration date 30-AUG-2020; dose, route and anatomical site were not provided) for prophylaxis instead of varicella virus vaccine live (Oka/Merck) (VARIVAX). Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was reconstituted with a properly stored sterile diluent (lot number and expiration date were unknown by the reporter). No adverse effect reported.
Edema, Redness, Pain, rash all over the left leg. Treatment: Clindamycin (5 CC every 6 hours X 7 days), PRELONE (5 CC every 12 hours x 5 days), ZANTAC (5 CC twice a day).
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 29-JAN-2015, the patient was vaccinated with a dose of ZOSTAVAX (dose number was not reported), lot # J013449, 0.65 ml, subcutaneous route, which was expired on 24-JAN-2015. No adverse effect reported. Co-suspect and concomitant therapies were not reported. Additional information has been requested.
When woke up the next morning (11/1/09) left side of neck was swollen.  Was tender to touch.  Child stated was "swallowing funny".  No fever. No problems breathing.  Injection site clear.Went to local prompt care later that morning.  Was prescribed antibiotic
Patient's left deltoid and surrounding area of injection site appears erythematous even after 1 month after injection. Patient had no reaction to the first dose back in March 2022.
have a numbness/tingling feeling in my left cheek; have a numbness/tingling feeling in my left cheek; swell in my cheek area under my eye; then my lips, chin and nose started to feel numb and tingle; then my lips, chin and nose started to feel numb and tingle; then my lips, chin and nose started to feel numb and tingle; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Sep2021 16:45 (Lot number: 30130BA) at the age of 38 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Bees" (unspecified if ongoing), notes: Known allergies: Bees; "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes; "Asthma" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Adrenaline for Allergy. Vaccination history included: Bnt162b2 (prev dose product=COVID 19,, prev dose brand=Pfizer,, prev dose lot number=EW0187,, prev dose administration date=26Aug2021,, prev dose administration time=04:15 PM, prev dose dose number=1,, prev dose vaccine location=Left arm), administration date: 26Aug2021, when the patient was 38 years old, for Covid-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 16Sep2021 16:45, outcome "recovered" (Sep2021) and all described as "have a numbness/tingling feeling in my left cheek"; SWELLING FACE (non-serious) with onset 16Sep2021 16:45, outcome "recovered" (Sep2021), described as "swell in my cheek area under my eye"; HYPOAESTHESIA ORAL (non-serious), HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 16Sep2021 16:45, outcome "recovered" (Sep2021) and all described as "then my lips, chin and nose started to feel numb and tingle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of hypoaesthesia, paraesthesia, swelling face, hypoaesthesia oral, hypoaesthesia, paraesthesia.  Additional information: Facility type Vaccine was Workplace clinic. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. All the event were stayed for about 24hr. Therapeutic measures were taken as a result of events.  No follow-up attempts are possible. No further information is expected.
pt recv vax next day fever 100, aches, nausea; 2 days nausea, fever 10, weakness, sl rash; 3 days rash over entire body, low grade fever;
Lump and pain on arm at the site of administered vaccine.  Weakness and pain in arm.  Lump still there today.
I tested positive on 1/24, I had mild symptoms. I called my doctor and I got PAXLOVID on 1/24. On Jan 25 I had elevated heart rate, in the morning of the 26th I went to the ER. I was diagnosed with Atrial Fibrillation, I sent home with two medications, By the Jan 30th Palpitations went away.
dizzy x 2 days, week, paleness, hoarseness, sore throat, tiredness, severe pain at injection site on and off after pain had gone away.  Pain came back many days after.
Fever of 102 for 24 hours, severe chills for 8 hours, headache for 36 hours, fatigue for 48 hours, arm pain (no swelling), nauseous for 24 hrs.
Mother called reporting Headache and nauseam then dizziness and eyes moving side to side while sitting like a "small seizure" in her words.
Patient was getting their 2nd covid immunization.  They marked that they once had fainted from a previous immunization and had needle anxiety.  I asked her if she had fainted anytime recently or during the first covid vaccine and she said no.  Gave her the vaccine and let her remain in the chair.  She then had gotten a little dizzie for a moment, and then told us she had just fainted. We called store management code white.  We got her history, some soda, and ice pack.  She didn't fall out of the chair but thought it would help her feel better.   She stated she hadn't eaten much today and just got done working out at the gym and had low blood sugar.  We checked her pulse Ox and heart rate and everything was within normal limits.  We had her remain to she felt comfortable to leave.  She didn't have any HX of seizures and and no signs of allergic reaction. Staff Said when she was here first time she had immunization anxiety and hung out for 40ish minutes but didn't faint first time.
got the flu shot September 2019 and in November 2019, got sicker than heck with some thing; Initial information regarding this unsolicited valid non-serious social media case received from a consumer (patient) and transmitted to Sanofi on 12-Dec-2020.  This case involved a patient who got the flu shot September 2019 and in November 2019, got sicker than heck with some thing (Illness), after receiving vaccine INFLUENZA VACCINE.  Relevant medical history, concomitant medications and family history were not provided.  On an unknown date in September 2019, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date in November 2019, the patient experienced a non-serious got the flu shot September 2019 and in November 2019, got sicker than heck with some thing (Illness), approximately 2 months following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.  Final diagnosis was  illness.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There would be no information available on batch number for this case.
Sore arm; Mild fatigue and tiredness for a couple days.; A couple swollen lymph nodes after the first shot (still lingering).; Perhaps congestion and phlegm (that could have been allergies too though but it did seem increased for 2 days after the shot); Perhaps congestion and phlegm (that could have been allergies too though but it did seem increased for 2 days after the shot); This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on 01Apr2021 at 16:00 (at the age of 33-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration on 22Apr2021 at 16:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D3), vitamin e nos (VITAMIN E) and ascorbic acid (VITAMIN C) and multi-vitamins (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, the patient experienced sore arm, mild fatigue and tiredness for a couple days. A couple swollen lymph nodes after the first shot (still lingering). Perhaps congestion and phlegm (that could have been allergies too though but it did seem increased for 2 days after the shot). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, mild fatigue, tiredness, swollen lymph nodes after the first shot (still lingering), perhaps congestion and phlegm were recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical technician, refers to a 24 year old female patient. No patient's medical history, drug reactions, allergies or concurrent conditions were reported. On 10-AUG-2018, the patient was vaccinated with the first dose of GARDASIL 9 (lot number R004689 with expiration date on 29-NOV-2020) for prophylaxis, however route of administration was not reported. On 25-MAR-2019, the primary reporter stated that the patient was in the office to receive the second or third dose of GARDASIL 9 series as the patient was unsure if she already received the second dose or not. At the time of reporting it was unknown if the patient had recovered from the event.
Blotchy welts on right cheek, front and back of thighs, and fever.
Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat). At the time of the report, OROPHARYNGEAL PAIN (Sore throat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up information was received and the outcome of event was updated.
Dizziness, Vertigo, Leg pain, memory issues (patient reports as "brain fog")
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown demographics. Patients medical history and concurrent conditions were not reported. From 20-APR-2015 to 29-APR-2015, RECOMBIVAX HB (lot # K014548, expiration date: 27-AUG-2016) was improperly exposed to 26F for about 216 hours. On an unknown date in 2015, unspecified number of patients might receive RECOMBIVAX HB (dose, route of administration and anatomical location was unknown) which were improperly stored. Concomitant medications were unspecified by reporter. No known adverse effects reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
5.5 x 4 cm erythematous, slightly warm circular rash on (L) upper arm-lateral at site of MMRV vaccine. Bruising started on 7/2/15. Redness started on 7/6/15.
1st dose 28Jan2020, 2nd not yet; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 28th January 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 20-FEB-2023 Reporter's comment: The reporter was the wife of patient.  The patient had not yet received the second dose. The patient received the vaccine at a pharmacy but the pharmacy had since closed.   The reporter did not consent to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. This case is linked with US2023028619, reported by same reporter. Details pertains to 1st dose of Shingrix in product tab; Sender's Comments:  US-GSK-US2023028620:Same reporter
Patient was on the schedule for a follow up visit and a pfizer booster which was noted in the appointment comments. Patient completed the Vaccination screening form as well and COVID 19 Vaccination record to receive pfizer booster. Patient did not have vaccination record card and stated would like a new card. This nurse reviewed in EMR previous dosed of pfizer on the EMR vaccination record which stated las pfizer doses were 5/19/2021 and 6/9/2021. It appeared patient was due for booster. This nurse reviewed  Prevaccination Checklist for COVID 19 with patient the form stated patient had 2 dosed of pfizer no other COVID vaccine.  This nurse administered the pfizer 0.3ml dose. After patient left this nurse tried to put vaccine in system and it stated that the booster dose had been given. This nurse checked the medical record where in fact it did show patient was administered a moderna booster on 12/7/2021, but it was in separated from the pfizer dose in the EMR as it is two different types of COVID vaccines. This nurse missed it. If this nurse would have pulled the state vaccine record it would have been caught. This nurse did follow up with the patient the next day to explain that he received an extra booster dose as he recieved a booster on 12/7/2021, pt voiced understanding and stated that he felt fine and reported no adverse reaction.
pt recvd vax & woke up screaming; pt had fever w/ t 102 & would not nurse or swallow; became limp, had whining type respiration; L knee pink & puffy & sensitive;
This spontaneous report as received from an immunization coordinator refers to an unknown number of patients of unknown age and gender. The immunization coordinator mentioned VARIVAX was improperly stored and might have been given to an unknown number of patients. VARIVAX was exposed to temperatures of 11F (Fahrenheit) for 853 hours then 15F for 297 hours (according to assessment data, these products should be used within 1 month). No adverse effects reported. This is one of several reports received from the same reporter (MARRS # 1404USA012060, 1404USA012061, 1404USA012063 and 1402USA007570). Additional information has been requested.
Pt received second dose of varicella virus vaccine live on 08/13/1998. ELISA testing on 10/23/1998 revealed negative seroconversion.
Reaction within minutes, described as if she was given morphine.  Dizziness and slurred speech right away.  Both arms started being uncoordinated.  Within two hours there was extreme pain in both arms and paralysis and pain on the left side of the body.  Slurred speech got worse.  Trouble walking.  Went to Hospital by about 4:30 PM.  Dr decided to try an allergic reaction cocktail, ask hospital for specifics.  Saline drip and a cocktail put her to sleep for a few hours.  She did need to be put on oxygen for a little while.  By about 10:30 she was able to talk more clearly and walk better.  They sent us home with instructions to have her take 20 - 50 mg of Benadryl every 6 hours as needed for the next couple of days.
Light red spots on chest and back for 24 hours, loose bowel movements for 4 days. Both symptoms started on 4/5/2000.
pt recvd vax 24MAR93 lt arm swollen/red from shoulder to elbow according to mom; sl fever; t102; 28MAR93 relieved w/APAP; also c/o achey lower extremities;
Patient received COVID-19 vaccine at assisted living facility. Had myalgia symptoms from 01/08/21-01/21/21. Has resolved since.
A terrible headache made me awake in the morning. Toothache as if I have a gum problem. Drinking cold water was a problem. All teeth are causing pain Tooth ache during chewing. Overall body ache
Pt developed swelling at injection site, non-tender. Swelling resolved within 4-5 day.
evening p/flu vax pt devel h/a, blinding h/a hurts all over;should cont to get flu shot in the future;flu sx, nose running, cold sx, fever, eyes hurt;